{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T01:32:55Z","timestamp":1773365575144,"version":"3.50.1"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00134-022-06651-y","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T09:04:04Z","timestamp":1647939844000},"page":"611-612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Absence of candidemia in critically ill patients with COVID-19 receiving selective digestive decontamination"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4031-0778","authenticated-orcid":false,"given":"Jochem B.","family":"Buil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9118-4420","authenticated-orcid":false,"given":"Jeroen A.","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5983-3897","authenticated-orcid":false,"given":"Joost","family":"Wauters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7185-8045","authenticated-orcid":false,"given":"Hans","family":"van de Hoeven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8600-9860","authenticated-orcid":false,"given":"Paul E.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"CAC-SDD study group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"issue":"2","key":"6651_CR1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","volume":"10","author":"JP Gangneux","year":"2022","unstructured":"Gangneux JP, Dannaoui E, Fekkar A, Luyt CE, Botterel F, De Prost N et al (2022) Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. Lancet Respir Med 10(2):180\u2013190","journal-title":"Lancet Respir Med"},{"issue":"12","key":"6651_CR2","doi-asserted-by":"publisher","first-page":"ofab510","DOI":"10.1093\/ofid\/ofab510","volume":"8","author":"JW Baddley","year":"2021","unstructured":"Baddley JW, Thompson GR 3rd, Chen SC, White PL, Johnson MD, Nguyen MH et al (2021) Coronavirus disease 2019-associated invasive fungal infection. Open Forum Infect Dis 8(12):ofab510","journal-title":"Open Forum Infect Dis"},{"issue":"6499","key":"6651_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.abc1669","volume":"369","author":"MM Lamers","year":"2020","unstructured":"Lamers MM, Beumer J, van der Vaart J, Knoops K, Puschhof J, Breugem TI et al (2020) SARS-CoV-2 productively infects human gut enterocytes. Science 369(6499):50\u201354","journal-title":"Science"},{"issue":"1","key":"6651_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa0800394","volume":"360","author":"AM de Smet","year":"2009","unstructured":"de Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS et al (2009) Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 360(1):20\u201331","journal-title":"N Engl J Med"},{"issue":"6","key":"6651_CR5","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1007\/s00134-016-4238-2","volume":"42","author":"SH Buitinck","year":"2016","unstructured":"Buitinck SH, Zandstra DF, van der Voort PH (2016) ICU-acquired candidemia within SDD: low incidence in a 20-year longitudinal database. Intensive Care Med 42(6):1094\u20131095","journal-title":"Intensive Care Med"},{"issue":"11","key":"6651_CR6","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s00134-015-4004-x","volume":"41","author":"JC Hurley","year":"2015","unstructured":"Hurley JC (2015) ICU-acquired candidemia within selective digestive decontamination studies: a meta-analysis. Intensive Care Med 41(11):1877\u20131885","journal-title":"Intensive Care Med"},{"issue":"15","key":"6651_CR7","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1001\/jama.2016.14655","volume":"316","author":"JF Timsit","year":"2016","unstructured":"Timsit JF, Azoulay E, Schwebel C, Charles PE, Cornet M, Souweine B et al (2016) Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, candida colonization, and multiple organ failure: the EMPIRICUS randomized clinical trial. JAMA 316(15):1555\u20131564","journal-title":"JAMA"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-022-06651-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-022-06651-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-022-06651-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T06:03:26Z","timestamp":1651125806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-022-06651-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["6651"],"URL":"https:\/\/doi.org\/10.1007\/s00134-022-06651-y","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,22]]},"assertion":[{"value":"16 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JBB reported grants from Gilead Sciences and F2G. JAS has received unrestricted educational and resarch grants from MSD and has been an advisor to Pfizer. JW  reported grants from Gilead Sciences, MSD and Pfizer, and non-financial support from Gilead Sciences, Pfizer and MSD. PEV reported grants from Gilead Sciences, MSD, Pfizer and F2G, and non-financial support from OLM and IMMY. All reported grants were outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}